These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17877104)

  • 1. Getting ready for certification: urinary tract inflammation and disease.
    Linn MM
    Urol Nurs; 2007 Aug; 27(4):324-5. PubMed ID: 17877104
    [No Abstract]   [Full Text] [Related]  

  • 2. Getting ready for certification: obstructive uropathy.
    Matthews PA
    Urol Nurs; 2004 Feb; 24(1):45, 61. PubMed ID: 15054910
    [No Abstract]   [Full Text] [Related]  

  • 3. Male lower urinary tract symptoms and sildenafil.
    Jackson G
    Int J Clin Pract; 2007 Nov; 61(11):1779. PubMed ID: 17935539
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical management of lower urinary tract symptoms with combined medical therapy.
    Roehrborn CG
    BJU Int; 2008 Nov; 102 Suppl 2():13-7. PubMed ID: 19032605
    [No Abstract]   [Full Text] [Related]  

  • 5. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms.
    Lemack GE
    Nat Clin Pract Urol; 2007 Apr; 4(4):174-5. PubMed ID: 17415351
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of hydroxyprogesterone caproate on experimental benign prostatic obstruction in the mouse.
    Caine M; Superstine E
    Isr J Med Sci; 1973; 9(11):1559-64. PubMed ID: 4130461
    [No Abstract]   [Full Text] [Related]  

  • 7. Getting ready for certification: benign prostatic hyperplasia.
    Secrist J
    Urol Nurs; 2000 Aug; 20(4):266. PubMed ID: 11998090
    [No Abstract]   [Full Text] [Related]  

  • 8. Cardiovascular effects of alpha-blockers for the treatment of symptomatic BPH.
    de Mey C
    Eur Urol; 1998; 34 Suppl 2():18-28; discusion 47. PubMed ID: 9732829
    [No Abstract]   [Full Text] [Related]  

  • 9. [Generally effective for unstable bladder? Tamsulosin: application not limited to benign prostatic hyperplasia].
    Urologe A; 2003 Feb; 42(2):301-2. PubMed ID: 12739514
    [No Abstract]   [Full Text] [Related]  

  • 10. Getting ready for certification: medications for benign prostatic hyperplasia (BPH).
    Matthews PA
    Urol Nurs; 2008 Dec; 28(6):478-9. PubMed ID: 19241789
    [No Abstract]   [Full Text] [Related]  

  • 11. [Alfuzosin in benign prostatic hyperplasia. A new principle is evaluated. Report of a study].
    Fortschr Med Suppl; 1995; 166():1-12. PubMed ID: 7537599
    [No Abstract]   [Full Text] [Related]  

  • 12. Silodosin (Rapaflo) for benign prostatic hyperplasia.
    Med Lett Drugs Ther; 2009 Jan; 51(1303):3-4. PubMed ID: 19122568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenoxybenzamine reduces bladder outlet obstruction in benign prostatic hyperplasia. A urodynamic investigation.
    Gerstenberg T; Blaabjerg J; Nielsen ML; Clausen S
    Invest Urol; 1980 Jul; 18(1):29-31. PubMed ID: 6157651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Taming the overgrown prostate.
    Willis D
    Am J Nurs; 1992 Feb; 92(2):34-40. PubMed ID: 1371203
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of candicidin on the human benign hypertrophied prostate gland.
    Keshin JG
    Int Surg; 1973 Feb; 58(2):116-22. PubMed ID: 4119813
    [No Abstract]   [Full Text] [Related]  

  • 16. [Correlation of the factors on benign prostatic hyperplasia combined with obstruction].
    Chen Q; Wang YX
    Zhonghua Nan Ke Xue; 2002; 8(4):299-301. PubMed ID: 12491701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Re: Bladder outflow tract obstruction and urinary retention from benign prostatic hypertrophy treated by balloon dilatation.
    Klein L
    Br J Urol; 1990 Oct; 66(4):443. PubMed ID: 1699630
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical aspects of benign prostatic hypertrophy].
    Pisani E; Montanari E; Trinchieri A
    J Urol (Paris); 1993; 99(6):288-9. PubMed ID: 7516368
    [No Abstract]   [Full Text] [Related]  

  • 19. Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia.
    Oelke M; Baard J; Wijkstra H; de la Rosette JJ; Jonas U; Höfner K
    Eur Urol; 2008 Aug; 54(2):419-26. PubMed ID: 18325657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bladder outflow obstruction treated with phenoxybenzamine.
    Abrams PH; Shah PJ; Stone R; Choa RG
    Prog Clin Biol Res; 1981; 78():269-75. PubMed ID: 6174998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.